Ekta Batra

A new study reveals that black plastic kitchen utensils often contain toxic flame retardants, likely due to the recycling of electronic waste, posing significant health risks such as cancer and hormone disruption.

India needs more concert venues and the artists need to plan more shows to meet the growing number of fans and their appetite for live gigs.

The Central Drugs Standards Control Organisation (CDSCO) has recently released a list identifying 53 drugs as Not Standard Quality (NSQ), which has

In a significant development, global pharmaceutical companies Mylan and Novo Nordisk have reached a confidential settlement in the US regarding the

Hyundai Motor Company, the South Korean parent of Hyundai Motor India, plans to sell up to 142.19 million equity shares, with a price band between ₹1,865 and ₹1,960 per share. Ahead of the IPO, CNBC-TV18 spoke to Gurmeet Chadha, Managing Partner & CIO at Complete Circle; Abhishek Gaoshinde, Deputy VP of Research at Sharekhan by BNP Paribas; and Mayuresh Joshi, Head of Equity Research at William O' Neil, to assess the valuation, timing, and whether investors should subscribe.

Wockhardt is also looking towards international markets. Khorakiwala mentioned that Saudi Arabia has accepted Nafithromycin as a breakthrough medicine, with Wockhardt planning to apply for approval there as well.

The most notable contributor to exports was the launch of the Xanomeline Active Pharmaceutical Ingredient (API). After receiving regulatory approval on September 26, the supplies commenced, generating $13 million in exports.

Within a year of its launch, Orange Health became Bengaluru's largest COVID-19 testing lab. Since then, it has expanded its operations to several other cities, gaining a notable market share and positioning itself as a formidable competitor in the growing diagnostics industry.

Gulam Zia, the Senior Executive Director at Knight Frank India noted that developers shifted focus to the upper-end market, where margins and sales velocity were more favorable.

Divi’s Labs shares slide as US Court rejects Novartis challenge on generic Entresto approval